Clinical Development
Phase 3 Clinical Trial
Large-scale studies (typically 300-3000+ patients) designed to confirm efficacy, monitor side effects, and compare to standard of care. Forms basis for regulatory approval.
See How Phase 3 Clinical Trial Affects Deal Economics
Model deal terms with real benchmark data from 3,000+ biopharma transactions.